Omada Health, Inc. (NASDAQ:OMDA) Receives $25.10 Average Target Price from Analysts

Shares of Omada Health, Inc. (NASDAQ:OMDA) have been assigned a consensus recommendation of “Moderate Buy” from the eleven ratings firms that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and eight have issued a buy rating on the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $25.10.

Several brokerages recently issued reports on OMDA. Weiss Ratings reiterated a “sell (d)” rating on shares of Omada Health in a report on Thursday, January 22nd. The Goldman Sachs Group reiterated a “buy” rating and issued a $26.00 target price on shares of Omada Health in a research note on Friday, January 16th. BMO Capital Markets assumed coverage on Omada Health in a report on Thursday, November 13th. They set an “outperform” rating and a $27.00 target price on the stock. Barclays decreased their price target on Omada Health from $29.00 to $22.00 and set an “overweight” rating for the company in a report on Monday, January 5th. Finally, Needham & Company LLC reissued a “buy” rating and set a $28.00 target price on shares of Omada Health in a research report on Thursday, January 22nd.

Omada Health Stock Up 0.7%

Omada Health stock opened at $11.31 on Wednesday. The firm has a fifty day moving average of $14.89 and a 200-day moving average of $19.37. Omada Health has a 52-week low of $10.28 and a 52-week high of $28.40. The firm has a market capitalization of $654.94 million and a P/E ratio of -45.24.

Insider Buying and Selling at Omada Health

In other news, President Wei-Li Shao sold 5,618 shares of Omada Health stock in a transaction dated Monday, December 29th. The stock was sold at an average price of $16.13, for a total transaction of $90,618.34. Following the sale, the president directly owned 69,079 shares of the company’s stock, valued at approximately $1,114,244.27. The trade was a 7.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Sean P. Duffy sold 40,796 shares of the stock in a transaction dated Tuesday, January 13th. The shares were sold at an average price of $15.95, for a total value of $650,696.20. Following the completion of the transaction, the chief executive officer directly owned 126,644 shares of the company’s stock, valued at $2,019,971.80. This represents a 24.36% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 276,893 shares of company stock worth $4,336,787 in the last ninety days.

Hedge Funds Weigh In On Omada Health

A number of institutional investors have recently made changes to their positions in OMDA. Marshall Wace LLP purchased a new position in shares of Omada Health during the 4th quarter valued at approximately $3,442,000. Archon Capital Management LLC raised its holdings in Omada Health by 125.1% in the fourth quarter. Archon Capital Management LLC now owns 678,120 shares of the company’s stock valued at $10,701,000 after acquiring an additional 376,808 shares in the last quarter. AlpInvest Partners B.V. bought a new position in Omada Health during the 4th quarter valued at $850,000. Walleye Capital LLC grew its holdings in Omada Health by 59.1% during the 4th quarter. Walleye Capital LLC now owns 45,346 shares of the company’s stock worth $716,000 after acquiring an additional 16,846 shares in the last quarter. Finally, Quarry LP bought a new stake in shares of Omada Health in the 4th quarter worth about $29,000.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.